Safety Surveillance Adviser (temporary position), Global Safety
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Søborg
Would you like to be part of one of the most skilled and advanced pharmacovigilance functions in Denmark? Do you want to play a key role in ensuring highest safety and lowest possible risk to patients who use Novo Nordisk obesity products?
If so, you may be our new colleague in the Safety Surveillance Obesity & NASH 2 team at Novo Nordisk. Apply today!
About Safety Surveillance
Safety Surveillance is a department within Global Safety currently situated in Soeborg, Denmark. Our team of dedicated and skilled professionals has global responsibility for surveillance of all safety information for Novo Nordisk’s products that are currently marketed or under development.
The Position
You will be supporting the ongoing safety surveillance of products in clinical development/early post-marketing stage within weight management:
It will be your job to:
You will get the opportunity to work both independently and in collaboration with a team of highly skilled, committed and enthusiastic colleagues in Safety Surveillance and across the functional areas in Novo Nordisk, especially the Non-Clinical, Clinical Development and Regulatory Affairs teams. Assuming responsibility, communicating information and taking action will be essential parts of your workday.
Qualifications
As an ideal candidate, you have:
As a person you are ethical, responsible, well-organised and a strong communicator. You are self-driven, able to work independently and under pressure when needed. You are a strong collaborator and a dedicated team player who thrives in a multicultural environment of continuous development, and you are good at establishing contact and collaborating with stakeholders.
You are fluent in English both written and spoken (company language) and an experienced user of MS Office.
Working at Novo Nordisk
At Novo Nordisk, we do not wait for change. We drive it. We are a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development, through to manufacturing, marketing and sales – we are all working to move the needle on patient care.
Contact
For further information please contact Nina Engberg Jungdal at +45 3079 9913.
Deadline
Please apply for the positions no later than 20 November 2022.
We will review the applications on an ongoing basis, so we encourage you to apply as soon as possible.
Please include a few sentences about why you are applying for this position in your resume or CV. You do not need to attach a cover letter to your application.
To ensure an efficient and fair recruitment process, please refrain from adding a photo to your CV.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.
At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
Print job Send to e-mail
If so, you may be our new colleague in the Safety Surveillance Obesity & NASH 2 team at Novo Nordisk. Apply today!
About Safety Surveillance
Safety Surveillance is a department within Global Safety currently situated in Soeborg, Denmark. Our team of dedicated and skilled professionals has global responsibility for surveillance of all safety information for Novo Nordisk’s products that are currently marketed or under development.
The Position
You will be supporting the ongoing safety surveillance of products in clinical development/early post-marketing stage within weight management:
It will be your job to:
- Perform critical analysis and medical evaluation of the emerging aggregate safety data and contribute to establishment of the product safety profile
- Participate in preparation of communication about the benefit risk assessment (such as Periodic Safety Update Reports, Development Safety Update Reports and Risk Management Plans)
- Contribute to development of clinical study protocols and clinical study reports
- Represent Safety Surveillance in cross-functional teams
You will get the opportunity to work both independently and in collaboration with a team of highly skilled, committed and enthusiastic colleagues in Safety Surveillance and across the functional areas in Novo Nordisk, especially the Non-Clinical, Clinical Development and Regulatory Affairs teams. Assuming responsibility, communicating information and taking action will be essential parts of your workday.
Qualifications
As an ideal candidate, you have:
- a university degree within Medicine or Natural Sciences (MD, DVM, MSc Pharm or equivalent), preferably complemented by a PhD
- a good understanding of medical concepts, disease processes, scientific methodology and data analysis
- experience with drug safety/pharmacovigilance or clinical development will be an advantage
As a person you are ethical, responsible, well-organised and a strong communicator. You are self-driven, able to work independently and under pressure when needed. You are a strong collaborator and a dedicated team player who thrives in a multicultural environment of continuous development, and you are good at establishing contact and collaborating with stakeholders.
You are fluent in English both written and spoken (company language) and an experienced user of MS Office.
Working at Novo Nordisk
At Novo Nordisk, we do not wait for change. We drive it. We are a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development, through to manufacturing, marketing and sales – we are all working to move the needle on patient care.
Contact
For further information please contact Nina Engberg Jungdal at +45 3079 9913.
Deadline
Please apply for the positions no later than 20 November 2022.
We will review the applications on an ongoing basis, so we encourage you to apply as soon as possible.
Please include a few sentences about why you are applying for this position in your resume or CV. You do not need to attach a cover letter to your application.
To ensure an efficient and fair recruitment process, please refrain from adding a photo to your CV.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.
At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
Print job Send to e-mail
Information og data
Denne ledige stilling har jobtypen "Forretningsudvikler", og befinder sig i kategorien "Kommunikation, marketing, salg".
Arbejdsstedet er beliggende i Søborg.
Jobbet er oprettet på vores service den 8.11.2022, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Forretningsudvikler
- Søborg
Lignende jobs
-
Strategic Trial Planning Manager - Clinical Develo...
Are you ready to drive the successful strategic planning and management of early phase clinical trials, i.e. ClinPharm/Phase 1 studies? Does oversight and cross functional collaboration motivate yo..Få mere info- Forretningsudvikler
- Søborg
-
Senior Scientist in Late-stage Downstream Developm...
Are you ready to shape the future of API process characterization in late-stage downstream development? Do you have the expertise to drive innovative solutions and ensure seamless tech transfer in .Få mere info- Forretningsudvikler
- Bagsværd
-
Global Trial Manager
Are you passionate about clinical development? Is ensuring that clinical trials produce high-quality data and scientific documentation your top priority? If so, we want you to join our team in Card..Få mere info- Forretningsudvikler
- Søborg
-
Udviklingskonsulent til det sociale børne- og unge...
Få mere info- Forretningsudvikler
- Taastrup
Statistik over udbudte jobs som forretningsudviklere i Søborg
Herunder ser du udviklingen i udbudte forretningsudvikler i Søborg over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal forretningsudviklere.
Se flere statistikker her:
Statistik over udbudte forretningsudviklere i Søborg over tid
| Dato | Alle jobs som forretningsudviklere |
|---|---|
| 22. november 2024 | 17 |
| 21. november 2024 | 17 |
| 20. november 2024 | 15 |
| 19. november 2024 | 12 |
| 18. november 2024 | 10 |
| 17. november 2024 | 10 |
| 16. november 2024 | 10 |
| 15. november 2024 | 10 |
| 14. november 2024 | 10 |
| 13. november 2024 | 9 |
| 12. november 2024 | 8 |
| 11. november 2024 | 8 |
| 10. november 2024 | 7 |
| 9. november 2024 | 7 |
| 8. november 2024 | 6 |
| 7. november 2024 | 6 |
| 6. november 2024 | 6 |
| 5. november 2024 | 6 |
| 4. november 2024 | 7 |
| 3. november 2024 | 6 |
| 2. november 2024 | 6 |
| 1. november 2024 | 6 |
| 31. oktober 2024 | 8 |
| 30. oktober 2024 | 7 |
| 29. oktober 2024 | 6 |
| 28. oktober 2024 | 6 |
| 27. oktober 2024 | 7 |
| 26. oktober 2024 | 7 |
| 25. oktober 2024 | 8 |
| 24. oktober 2024 | 8 |
| 23. oktober 2024 | 8 |